Sun Pharma Advanced Research Co Ltd (SPARC) Stock Price & News

SPARC:NSE

Sun Pharma Advanced Research Co Ltd

₹196.20

-0.59%

(-1.16) 1D

Aug 18, 10:56:53 AM GMT+5:30 · INR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Last report

Aug 10, 2026

Fiscal period

Q1 2027

EPS / Est. (INR)

- / -

Revenue / Est. (INR)

399.20M / -

Fiscal Q1 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	78.60M	84.50M	18.53B	399.20M
Cost of goods sold	61.00M	72.10M	115.06M	76.60M
Cost of revenue	61.00M	72.10M	115.06M	76.60M
Research and development expenses	80.10M	62.70M	28.44M	132.60M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	483.40M	424.60M	557.37M	448.00M
Operating expense	700.40M	604.50M	605.33M	684.60M
Total operating expenses	761.40M	676.60M	720.39M	761.20M
Operating income	-682.80M	-592.10M	17.81B	-362.00M
Other non operating income	100.00K	-	-116.03M	236.60M
EBT including unusual items	-757.90M	-803.50M	17.61B	-206.70M
EBT excluding unusual items	-757.90M	-679.90M	17.61B	-206.70M
Income tax expense	600.00K	700.00K	-3.84M	1.10M
Effective tax rate	-0.08%	-0.09%	-0.02%	-0.53%
Other operating expenses	111.30M	91.50M	-3.44M	82.00M
Net income	-758.50M	-804.20M	17.61B	-207.80M
Net profit margin	-965.01%	-951.72%	95.04%	-52.05%
Earnings per share	-	-	-	-
Interest and investment income	-	-	102.87M	-
Interest expense	-75.20M	-87.80M	-90.07M	-81.30M
Net interest expenses	-75.20M	-87.80M	12.80M	-81.30M
Depreciation and amortization charges	25.60M	25.70M	22.96M	22.00M
EBITDA	-656.60M	-570.75M	17.83B	-342.34M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance